Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Capranico

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|February 1, 1988
Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell lineR Supino, M Mariani, G Capranico, et al.
Cancer Research|July 15, 1987
Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nucleiG Capranico, A Riva, S Tinelli, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
DNA topoisomerase II poisons and inhibitorsG Capranico, G Giaccone, F Zunino, et al.
Cancer Research|April 1, 1992
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expressionG Giaccone, A F Gazdar, H Beck, et al.
Trends in Pharmacological Sciences|November 5, 1997
A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisonsG Capranico, M Binaschi, M E Borgnetto, et al.
Cancer Research|April 15, 1989
Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cellsG Capranico, P De Isabella, S Penco, et al.
Biochemistry|January 12, 1993
Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomersG Capranico, S Tinelli, F Zunino, et al.
Biochemistry|March 30, 1993
Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase IIG Capranico, P De Isabella, S Tinelli, et al.
Molecular Pharmacology|January 1, 1990
Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cellsP De Isabella, G Capranico, M Binaschi, et al.
Current Pharmaceutical Design|September 28, 2007
DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formationD Dal Ben, M Palumbo, G Zagotto, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|February 1, 1988
Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell lineR Supino, M Mariani, G Capranico, et al.
Cancer Research|July 15, 1987
Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nucleiG Capranico, A Riva, S Tinelli, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
DNA topoisomerase II poisons and inhibitorsG Capranico, G Giaccone, F Zunino, et al.
Cancer Research|April 1, 1992
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expressionG Giaccone, A F Gazdar, H Beck, et al.
Trends in Pharmacological Sciences|November 5, 1997
A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisonsG Capranico, M Binaschi, M E Borgnetto, et al.
Cancer Research|April 15, 1989
Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cellsG Capranico, P De Isabella, S Penco, et al.
Biochemistry|January 12, 1993
Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomersG Capranico, S Tinelli, F Zunino, et al.
Biochemistry|March 30, 1993
Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase IIG Capranico, P De Isabella, S Tinelli, et al.
Molecular Pharmacology|January 1, 1990
Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cellsP De Isabella, G Capranico, M Binaschi, et al.
Current Pharmaceutical Design|September 28, 2007
DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formationD Dal Ben, M Palumbo, G Zagotto, et al.
Pageof 9